EDAN Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 2025 Annual Report Summary
Securities Code: 300206 Securities Abbreviation: Mindray Medical Announcement No.: 2026-008
I. Important Notice
This annual report summary is derived from the full annual report. To fully understand the company's operating results, financial condition, and future development plans, investors should carefully read the full annual report on the designated media.
All directors have attended the board meeting to review this report.
Xinyongzhonghe Certified Public Accountants (Special General Partnership) provided an unqualified audit opinion on the company's financial report for the year: Standard unqualified opinion.
Non-standard audit opinion reminder □ Applicable Not applicable
The company was not profitable at the time of listing and is currently not profitable □ Applicable Not applicable
Reported period profit distribution plan or capital reserve to increase share capital plan reviewed by the Board of Directors ☑ Applicable Not applicable
The profit distribution plan reviewed by the Board of Directors for the reporting period is: Based on 579,663,346 shares, a cash dividend of RMB 3.11 per 10 shares (tax inclusive) will be distributed to all shareholders, with 0 bonus shares (tax inclusive), and 0 bonus shares from capital reserve per 10 shares to all shareholders.
Profit distribution plan for preferred shares in the reporting period approved by the Board of Directors □ Applicable Not applicable
II. Company Basic Information
- Company Profile
Stock Abbreviation: Mindray Medical Stock Listing Exchange: Shenzhen Stock Exchange Stock Code: 300206
Contacts and Contact Information
Name: Zu Dong Office Address: Jinhui Road 15, Jinsha Community, Kangci Street, Pingshan New District, Shenzhen Fax: 0755-26850550 Telephone: 0755-26851437 Email: IR@edan.com
Board Secretary: Si Chen Office Address: Jinhui Road 15, Jinsha Community, Kangci Street, Pingshan New District, Shenzhen Fax: 0755-26850550 Telephone: 0755-26851437 Email: IR@edan.com
- Brief Introduction to Main Business or Products
According to the "Classification of National Economic Industries" (GB/T4754-2017) issued by the National Bureau of Statistics, the company's industry belongs to the "Manufacturing of Special Equipment" category 35, specifically the sub-sector "Manufacturing of Medical Instruments and Devices" under "Manufacturing of Medical Diagnostic, Monitoring, and Treatment Equipment."
The medical device industry is constantly developing with the growth of human health needs and is known as a sunrise industry, attracting competition from developed countries worldwide. In 2020, during the pandemic, countries around the world further realized the significant impact of the medical device industry on national economy and people's livelihood. Especially in China, domestic medical device companies provided strong support for the country's epidemic prevention and control. At the same time, the industry is in a golden period of development, with its scale maintaining rapid growth for nearly a decade. In recent years, the state has gradually introduced a series of favorable policies to encourage innovation and accelerate approvals. The post-epidemic era will further promote public health reform and strengthen hospital departments, which is a medium-to-long-term policy benefit for China's medical device industry. In addition to the increasing emphasis on the medical device industry by the state, China's rapid economic development, the continuous aging of the population, and the strengthening of residents' health awareness will further expand the market size of China's medical devices.